Publication date: Aug 20, 2026
Post-exertional malaise (PEM), the defining feature of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), is increasingly recognized in individuals with Long COVID. Although traditionally viewed as symptom exacerbation and/or emergence of new symptoms following exertion, PEM may reflect disrupted coordination across interconnected physiological systems operating over distinct post-exertional timescales. Such disruption may result in altered post-exertional physiological trajectories that contribute to multisystem manifestations and potential cardiometabolic consequences. This perspective outlines a conceptual approach for investigating PEM through longitudinal assessment of post-exertional physiological trajectories while considering disease severity and underlying cardiometabolic health, including obesity and type 2 diabetes. Integrating these dimensions may help contextualize post-exertional responses, inform future longitudinal cardiometabolic profiling, facilitate patient stratification, and provide a framework for future mechanistic and interventional studies in ME/CFS and Long COVID.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | myalgic encephalomyelitis |
| disease | MESH | Long COVID |
| disease | MESH | symptom exacerbation |
| disease | MESH | obesity |
| disease | MESH | type 2 diabetes |
| disease | MESH | Allergy |
| pathway | REACTOME | Reproduction |
| disease | MESH | included |
| drug | DRUGBANK | Dimercaprol |
| disease | MESH | infection |
| disease | MESH | PAIS |
| disease | MESH | metabolic syndrome |
| disease | MESH | dis |
| disease | MESH | bed |
| drug | DRUGBANK | Tretamine |
| disease | MESH | car |
| drug | DRUGBANK | Metformin |
| drug | DRUGBANK | Glucagon |
| disease | MESH | chronic conditions |
| drug | DRUGBANK | Oxygen |
| disease | MESH | stroke |
| disease | MESH | dys |
| disease | MESH | tic |
| disease | MESH | syndromes |
| disease | MESH | neglected disease |
| disease | MESH | Orthostatic Intolerance |
| disease | MESH | myelitis |
| disease | MESH | COVID 19 |
| disease | MESH | fac |
| drug | DRUGBANK | Tolbutamide |
| disease | MESH | Coronavirus Infections |
| disease | MESH | Pneumonia Viral |